“A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease”, OH&RM, vol. 4, no. 4, pp. 19–26, Sep. 2023, doi: 10.38045/ohrm.2023.4.02.